NYMC Faculty Publications
Assessment of No-Observed-Effect-Levels for Dna Adducts Formation by Genotoxic Carcinogens in Fetal Turkey Livers
Author Type(s)
Faculty
DOI
10.1016/j.tox.2023.153714
Journal Title
Toxicology
First Page
153714
Document Type
Article
Publication Date
1-1-2024
Department
Pathology, Microbiology and Immunology
Abstract
For genotoxic carcinogens, covalent binding to DNA is a critical initiating event in tumorigenesis. The present research investigated dose-effect relationships of three genotoxic carcinogens representing different structural classes, 2-acetylaminofluorene (2-AAF), benzo[a]pyrene (B[a]P) and quinoline (QUI), to assess the existence of no-observed-effect-levels (NOELs) for the formation of DNA adducts. Carcinogens were administered into the air sac of fertilized turkey eggs over wide dose ranges in three daily injections on days 22 to 24 of incubation. DNA adducts were measured in the fetal turkey livers by the P-nucleotide postlabeling (NPL) assay. B[a]P and QUI produced DNA adducts in a dosage-related manner and exhibited NOELs at 0.65 and 0.35 mg/kg bw/day, respectively. In contrast, 2-AAF formed DNA adducts at all tested dosages down to 0.005 mg/kg bw/day. Benchmark dose (BMD) analysis identified the potencies of 2-AAF and QUI to be similar, while B[a]P was the least potent compound. Overall, findings in fetal turkey livers demonstrated that exposure levels to genotoxic compounds that do not result in DNA adducts can exist but are not evident with all carcinogens of this type. The use of mechanistic dose-effect studies for genotoxic endpoints can provide critical information for prioritization of concerns for risk assessment.
Recommended Citation
Kobets, T., Hickey, C., Johnson, G., Duan, J., Etter, S., Smith, B., & Williams, G. M. (2024). Assessment of No-Observed-Effect-Levels for Dna Adducts Formation by Genotoxic Carcinogens in Fetal Turkey Livers. Toxicology, 501, 153714. https://doi.org/10.1016/j.tox.2023.153714
